Search by Drug Name or NDC
NDC 11822-3319-00 Maxi Nicotine 4 mg/1 Details
Maxi Nicotine 4 mg/1
Maxi Nicotine is a ORAL LOZENGE in the HUMAN OTC DRUG category. It is labeled and distributed by Rite Aid Corporation. The primary component is NICOTINE.
MedlinePlus Drug Summary
Nicotine lozenges are used to help people stop smoking. Nicotine lozenges are in a class of medications called smoking cessation aids. They work by providing nicotine to your body to decrease the withdrawal symptoms experienced when smoking is stopped and to reduce the urge to smoke.
Related Packages: 11822-3319-00Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Nicotine Lozenges
Product Information
| NDC | 11822-3319 |
|---|---|
| Product ID | 11822-3319_28a98fe8-38f9-4c2f-b80c-6154c89868d6 |
| Associated GPIs | 46400010001700 |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Maxi Nicotine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | nicotine polacrilex |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LOZENGE |
| Route | ORAL |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | mg/1 |
| Substance Name | NICOTINE |
| Labeler Name | Rite Aid Corporation |
| Pharmaceutical Class | Cholinergic Nicotinic Agonist [EPC], Nicotine [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA210712 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 11822-3319-00 (11822331900)
| NDC Package Code | 11822-3319-0 |
|---|---|
| Billing NDC | 11822331900 |
| Package | 3 BOTTLE, PLASTIC in 1 BOX (11822-3319-0) / 24 LOZENGE in 1 BOTTLE, PLASTIC |
| Marketing Start Date | 2021-07-09 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |